Ascites

Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort study
Nguyen Thao Thi Nguyen, Nicole Diaz, Hadley Reid, Rebecca Previs, Laura J Havrilesky, Angeles Alvarez Secord, Andrew Berchuck

International Journal of Gynecologic Cancer Apr 2024, 34 (4) 528-534; DOI: 10.1136/ijgc-2023-005104
Symptomatic or asymptomatic recurrence of ovarian cancer: does it influence survival?
Karen Madland, Line Bjorge, Milada Cvancarova Småstuen, Anne Dørum, Ingvild Vistad

International Journal of Gynecologic Cancer Aug 2022, 32 (8) 1025-1031; DOI: 10.1136/ijgc-2022-003361
Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer
Dimitrios Nasioudis, Maureen Byrne, Emily M Ko, Ashley F Haggerty, Lori Cory, Robert L Giuntoli II, Sarah H Kim, Nawar A Latif

International Journal of Gynecologic Cancer Dec 2021, 31 (12) 1579-1583; DOI: 10.1136/ijgc-2021-002978
Persistent postoperative ascites successfully identified and treated with laparoscopic indocyanine green fluorescence
Rodrigo Fernandes, Cristina Anton, Andre Lopes, Alexandre Silva e Silva, Eric Leblanc, Ulysses Ribeiro Jr, Jesus Paula Carvalho

International Journal of Gynecologic Cancer Aug 2020, 30 (8) 1250-1251; DOI: 10.1136/ijgc-2020-001198
Correlation of differential ascites volume with primary cytoreductive surgery outcome, lymph node involvement, and disease recurrence in advanced ovarian cancer
Ingrid Lai, Maria N Daniel, Barry P Rosen, Taymaa May, Christine Massey, Tomer Feigenberg

International Journal of Gynecologic Cancer Jun 2019, 29 (5) 922-928; DOI: 10.1136/ijgc-2019-000310
Metabolic Markers and HSP60 in Chemonaive Serous Solid Ovarian Cancer Versus Ascites
Elisabet Hjerpe, Suzanne Egyhazi Brage, Marianne Frostvik Stolt, Hemming Johansson, Maria Shoshan, Elisabeth Åvall-Lundqvist

International Journal of Gynecologic Cancer Oct 2014, 24 (8) 1389-1394; DOI: 10.1097/IGC.0000000000000246
The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma
U. Saygili, S. Guclu, T. Uslu, O. Erten, E. Dogan

International Journal of Gynecologic Cancer Aug 2002, 12 (5) 438-442; DOI: 10.1136/ijgc-00009577-200209000-00005
Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up
C. Rudlowski, A.-K. Pickart, C. Fuhljahn, T. Friepoertner, B. Schlehe, S. Biesterfeld, W. Schroeder

International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 183-189; DOI: 10.1136/ijgc-00009577-200602001-00029
Elevated CA125 level associated with Meigs' syndrome: case report and review of the literature
A. Morán-Mendoza, G. Alvarado-Luna, G. Calderillo-Ruiz, A. Serrano-Olvera, C. M. LÓPEZ-GRANIEL, D. Gallardo-Rincón

International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 315-318; DOI: 10.1136/ijgc-00009577-200602001-00053
The influence of aquaporin-1 and microvessel density on ovarian carcinogenesis and ascites formation
J. H. Yang, Y. F. Shi, X. D. Chen, W. J. Qi

International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 400-405; DOI: 10.1136/ijgc-00009577-200602001-00074

Main menu

Ascites

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Ascites

Pages